Addition of MMF to Dual Immunosuppression Does Not Increase the Risk of Malignant Short‐Term Death After Liver Transplantation
Open Access
- 1 December 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (12) , 2961-2967
- https://doi.org/10.1111/j.1600-6143.2005.01117.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- De Novo Neoplasia After Liver Transplantation: An Analysis of Risk Factors and Influence on SurvivalLiver Transplantation, 2004
- Risk of malignancy with long-term immunosuppression in renal transplant recipientsKidney International, 2004
- De Novo Internal Neoplasms after Liver Transplantation: Increased Risk and Aggressive Behavior in Recent Years?American Journal of Transplantation, 2004
- Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of MalignancyAmerican Journal of Transplantation, 2003
- Data sources and structureAmerican Journal of Transplantation, 2003
- Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patientsTransplantation, 2002
- Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantationLiver Transplantation, 2002
- Risk factors for development of de novo neoplasia after liver transplantationLiver Transplantation, 2001
- De novo malignancies after liver transplantation: A major cause of late deathLiver Transplantation, 2001
- Analysis of causes of death in liver transplant recipients who survived more than 3 yearsLiver Transplantation, 2001